CytoSorbents Corp (CTSO) Q3 2026 Earnings Call Highlights: Cash Flow Breakeven, Margin ...
CytoSorbents Corp (CTSO) hit operating cash flow breakeven and lifted product gross margin to 75% in Q3 2026, while outlining an early 2027 de novo submission for DrugSorb ATR. Related Stocks: CTSO ,